TNF-α Inhibitors and Other Biologic Agents for the Treatment of Immune Checkpoint Inhibitor-Induced Myocarditis

With anti-PD-1 antibodies serving as a representative drug, immune checkpoint inhibitors (ICIs) have become the main drugs used to treat many advanced malignant tumors. However, immune-related adverse events (irAEs), which might involve multiple organ disorders, should not be ignored. ICI-induced my...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiaohang, Wu, Wei, Fang, Ligang, Liu, Yingxian, Chen, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283712/
https://www.ncbi.nlm.nih.gov/pubmed/35844550
http://dx.doi.org/10.3389/fimmu.2022.922782

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283712/
https://www.ncbi.nlm.nih.gov/pubmed/35844550
http://dx.doi.org/10.3389/fimmu.2022.922782

Ejemplares similares